2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Lymphoma
29
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
18
Lymphoma, Non-Hodgkin
17
Neuroblastoma
16
Leukemia, Myeloid, Acute
14
Leukemia
13
Hodgkin Disease
13
Central Nervous System Neoplasms
13
Small Cell Lung Carcinoma
10
Sarcoma
9
Brain Neoplasms
9
Recurrence
8
Medulloblastoma
8
Leukemia, Lymphocytic, Chronic, B-Cell
8
Rhabdoid Tumor
7
Multiple Myeloma
7
Lymphoma, B-Cell
7
Lung Neoplasms
7
Burkitt Lymphoma
7
Lymphoma, Mantle-Cell
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Lymphoma, B-Cell, Marginal Zone
6
Astrocytoma
6
Teratoma
5
Ovarian Neoplasms
5
Neoplasms, Germ Cell and Embryonal
5
Neoplasms
5
Glioma
5
Interventions
XENP 1595
2
Cancer Vaccines
2
Bevacizumab
2
Adjuvants, Immunologic
2
veliparib
1
glutathione pegylated liposomal doxorubicin
1
etoposide phosphate
1
enzalutamide
1
elacestrant
1
binimetinib
1
abemaciclib
1
Trastuzumab
1
Tissue Banks
1
Temozolomide
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
RAD1901
1
Patient Discharge
1
PF-07284890
1
Midazolam
1
Etoposide
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Diseases
×
etoposide phosphate
×
Clear all
NCT05762419
2026-01-28
FUS Etoposide for DMG
Columbia University
Phase 1
Recruiting
10 enrolled